Current Drug Targets
Title:Editorial (Hot Topic:Depression and Serotonin: A Never Ending Story)
Volume: 14 Issue: 5
Author(s): Donatella Marazziti
Affiliation:
Export Options
About this article
Cite this article as:
Marazziti Donatella, Editorial (Hot Topic:Depression and Serotonin: A Never Ending Story), Current Drug Targets 2013; 14 (5) . https://dx.doi.org/10.2174/1389450111314050001
DOI https://dx.doi.org/10.2174/1389450111314050001 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
49
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Application of the Phage Display Technology for the Development of Peptide- mediated Drug Delivery Systems through the Blood-Brain Barrier
Current Pharmaceutical Biotechnology The Neurovascular Unit: Focus on the Regulation of Arterial Smooth Muscle Cells
Current Neurovascular Research Attacking c-Myc: Targeted and Combined Therapies for Cancer
Current Pharmaceutical Design Polymorphism of UDP-Glucuronosyltransferase and Drug Metabolism
Current Drug Metabolism p-Cymene Modulate Oxidative Stress and Inflammation in Murine Macrophages: Potential Implication in Atherosclerosis
Cardiovascular & Hematological Agents in Medicinal Chemistry Prion Disease: Chemotherapeutic Strategies
Infectious Disorders - Drug Targets Nutrition in Adult Patients with Inflammatory Bowel Disease
Current Drug Targets Updates on GMSCs Treatment for Autoimmune Diseases
Current Stem Cell Research & Therapy Developmental Current and Future Therapy for Severe Asthma
Inflammation & Allergy - Drug Targets (Discontinued) MHC Class I TCR Engineered Anti-Tumor CD4 T Cells: Implications For Cancer Immunotherapy
Endocrine, Metabolic & Immune Disorders - Drug Targets New Perspectives for Melanoma Immunotherapy: Role of IL-12
Current Molecular Medicine LYP3, a New Bestatin Derivative for Aminopeptidase N Inhibition
Medicinal Chemistry Anti-inflammatory Effects of Variola Virus TNF Decoy Receptor in an Experimental Model of Contact Dermatitis
Current Pharmaceutical Biotechnology Ecto-ADP-Ribosyltransferases (ARTs): Emerging Actors in Cell Communication and Signaling
Current Medicinal Chemistry Applications of Human Umbilical Cord Blood Cells in Central Nervous System Regeneration
Current Stem Cell Research & Therapy Soybean Antigen Proteins and their Intestinal Sensitization Activities
Current Protein & Peptide Science Gene Therapy Approaches for Cardiovascular Diseases
Current Gene Therapy Assessment of rhIL-11 by Validated SE-LC Method and its Correlation with RP-LC and CZE Methods
Current Pharmaceutical Analysis Clinical Potential of Minocycline for Schizophrenia
CNS & Neurological Disorders - Drug Targets Multiple Sclerosis: Current and Future Treatment Options
Endocrine, Metabolic & Immune Disorders - Drug Targets